Detalhe da pesquisa
1.
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX).
Future Oncol
; 15(19): 2203-2209, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023100
2.
Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options.
Cancers (Basel)
; 15(11)2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296924
3.
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi).
Eur Urol Open Sci
; 28: 52-61, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337526
4.
Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomised controlled trial.
BMJ Open
; 7(9): e015154, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28918408
5.
miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.
Oncotarget
; 7(13): 16676-87, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26918338
6.
Compartment syndrome, rhabdomyolysis and risk of acute renal failure as complications of the lithotomy position.
J Nephrol
; 15(2): 183-5, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12018636